1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Is it possible to gain energy at work? A questionnaire study in primary health care
- Contribution to journal › Article
- 2010
-
Mark
Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds
- Contribution to journal › Article
- 2008
-
Mark
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up
- Contribution to journal › Article
- 2006
-
Mark
The transition of reported pain in different body regions--a one-year follow-up study.
- Contribution to journal › Article
- 2005
-
Mark
Communicative ability and support important when administrators at the local social insurance office meet disability pensioners
(2005) The 8tn Nordic Public Health Conference
- Contribution to conference › Poster
- 2003
-
Mark
Budesonide/formoterol in a single inhaler (Symbicort®) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months
- Contribution to journal › Article
- 2002
-
Mark
Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum
- Contribution to journal › Article
- 2000
-
Mark
A randomised study of sector resection with and without radiotherapy for women with node-negative stage I and II breast cancer
- Contribution to journal › Published meeting abstract
- 1998
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
- Contribution to journal › Article
- 1996
-
Mark
Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group
- Contribution to journal › Article
